Charles River Laboratories India Profile
Key Indicators
- Authorised Capital ₹ 30.05 Cr
as on 11-12-2024
- Paid Up Capital ₹ 28.79 Cr
as on 11-12-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 6.48%
(FY 2021)
- Profit 45.48%
(FY 2021)
- Ebitda -25.90%
(FY 2021)
- Net Worth 6.61%
(FY 2021)
- Total Assets -16.92%
(FY 2021)
About Charles River Laboratories India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.05 Cr and a paid-up capital of Rs 28.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Charles River Laboratories India Private Limited India is Shefali Jain as COMPANY SECRETARY. Prafulla Chitnis, Parampal Deol, Kevin Finn, and One other member serve as directors at the Company.
- CIN/LLPIN
U24119KA2008PTC047975
- Company No.
047975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2008
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Charles River Laboratories India Private Limited offer?
Charles River Laboratories India Private Limited offers a wide range of products and services, including Laboratory Reagents, Technical Training Services, Technical Skills Training, Clinical Reagents, Diagnostic Reagents.
Who are the key members and board of directors at Charles River Laboratories India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prafulla Chitnis  | Managing Director | 02-Jan-2009 | Current |
| Shefali Jain | Company Secretary | 30-Apr-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parampal Deol  | Director | 25-Aug-2022 | Current |
| Kevin Finn | Director | 25-Aug-2022 | Current |
| Jon Galli | Director | 13-Dec-2022 | Current |
Financial Performance and Corporate Structure Insights of Charles River Laboratories India.
Charles River Laboratories India Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 6.48% increase. The company also saw a substantial improvement in profitability, with a 45.48% increase in profit. The company's net worth moved up by a moderate rise of 6.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Charles River Laboratories India?
In 2021, Charles River Laboratories India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Charles River Laboratories India?
Charles River Laboratories India has a workforce of 52 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Charles River Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Charles River Laboratories India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
